Brand Recall Hub

Important Recalls in Canada

15 recalls found for Important. Data sourced from Health Canada, CFIA, and Transport Canada. Updated daily.

15 Important Recalls

Other
2025-12-10

Important Safety Information on Yescarta (axicabtagene ciloleucel) and the Risk of Cerebral Edema in Primary Mediastinal B Cell Lymphoma (PMBCL)

New safety information

View recall details →
Other
2025-08-25

Important Safety Information on CRYSVITA (burosumab) and the Risk of Severe Hypercalcemia in Patients with Tertiary Hyperparathyroidism

New safety information - Product safety

View recall details →
Other
2025-08-21

Important Safety Information on COPAXONE (glatiramer acetate) and the Risk of Anaphylactic Reactions Which May Occur at Any Time Following Initiation of Treatment

New safety information - Product safety - Adverse reaction

View recall details →
Other
2024-06-07

Important Safety and Efficacy Information on ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) – Market Withdrawal and Continued Restricted Access

New safety information - Product withdrawal

View recall details →
Other
2021-08-19

Important Safety Information on Ultrasound Gels and Lotions Manufactured by Eco-Med Pharmaceuticals, Inc. - Potential Contamination with Burkholderia stabilis

Medical devices - Product safety

View recall details →
Other
2021-01-07

Important Safety Information on SUBOXONE (buprenorphine and naloxone) and the Risk of Overdose or Underdose when Switching Between Dosage Forms or Routes of Administration

Product safety

View recall details →
Other
2020-06-09

Important safety information for certain respirator masks

COVID - Product safety

View recall details →
Other
2020-05-13

Important Safety Information - Importation of Teva UK-labelled Salamol CFC-Free (Salbutamol Sulfate) Inhaler due to Shortage

Product safety

View recall details →
Other
2019-08-20

Health Canada reminds Canadians of important summer food safety tips

View recall details →
Other
2019-05-30

Important Safety Information on Alaris Infusion Sets and Alaris 8100 Pump Module - Risk of Over-Infusion

New safety information - Medical devices

View recall details →
Other
2019-05-21

Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity

View recall details →
Other
2019-01-31

Important new safety information regarding the use of hydrochlorothiazide and the risk of non-melanoma skin cancer

Product safety

View recall details →
Other
2019-01-30

LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions

Product safety

View recall details →
Other
2018-11-07

Several store-brand pain or sinus relief tablets recalled because consumers may be unable to access important safety information

Labelling

View recall details →
Other
2018-06-01

Important sunscreen safety tips for Canadians

Product safety

View recall details →